The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Research Report 2025
Synopsis
Diabetic retinopathy (DR) represents a major cause of visual impairment in developed countries. The ever-growing incidence of DR and its complications necessitates new strategies to screen patients, prevent complications and optimize management. For this reason, DR is a major target of AI-based models, especially those that can be used for large-scale screening. AI models should recognize DR-related alterations, such as haemorrhages, exudates, cotton wool spots and neovascularization; and, starting from fundus images, establish the presence or absence of DR, and grade it according to the conventional DR grading scales.
The global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market was valued at US$ 86.8 million in 2023 and is anticipated to reach US$ 6767 million by 2030, witnessing a CAGR of 84.8% during the forecast period 2024-2030.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy.
This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy (DR) Artificial Intelligence Screening System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy (DR) Artificial Intelligence Screening System.
The Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Retinopathy (DR) Artificial Intelligence Screening System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Segment by Type
Hardware
Software
Segment by Application
Medical Institutions
Great Health Scene
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy (DR) Artificial Intelligence Screening System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diabetic retinopathy (DR) represents a major cause of visual impairment in developed countries. The ever-growing incidence of DR and its complications necessitates new strategies to screen patients, prevent complications and optimize management. For this reason, DR is a major target of AI-based models, especially those that can be used for large-scale screening. AI models should recognize DR-related alterations, such as haemorrhages, exudates, cotton wool spots and neovascularization; and, starting from fundus images, establish the presence or absence of DR, and grade it according to the conventional DR grading scales.
The global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market was valued at US$ 86.8 million in 2023 and is anticipated to reach US$ 6767 million by 2030, witnessing a CAGR of 84.8% during the forecast period 2024-2030.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy.
This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy (DR) Artificial Intelligence Screening System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy (DR) Artificial Intelligence Screening System.
The Diabetic Retinopathy (DR) Artificial Intelligence Screening System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Retinopathy (DR) Artificial Intelligence Screening System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Retinopathy (DR) Artificial Intelligence Screening System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Segment by Type
Hardware
Software
Segment by Application
Medical Institutions
Great Health Scene
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy (DR) Artificial Intelligence Screening System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Institutions
1.3.3 Great Health Scene
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Perspective (2019-2030)
2.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Growth Trends by Region
2.2.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Historic Market Size by Region (2019-2024)
2.2.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Region (2025-2030)
2.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Dynamics
2.3.1 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Industry Trends
2.3.2 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Drivers
2.3.3 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Challenges
2.3.4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Revenue
3.1.1 Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Revenue (2019-2024)
3.1.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue
3.4 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Concentration Ratio
3.4.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue in 2023
3.5 Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System Head office and Area Served
3.6 Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Product and Application
3.7 Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Breakdown Data by Type
4.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Historic Market Size by Type (2019-2024)
4.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Type (2025-2030)
5 Diabetic Retinopathy (DR) Artificial Intelligence Screening System Breakdown Data by Application
5.1 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Historic Market Size by Application (2019-2024)
5.2 Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)
6.2 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)
6.4 North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)
7.2 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)
7.4 Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)
8.2 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)
9.2 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)
9.4 Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (2019-2030)
10.2 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Details
11.1.2 Airdoc Technology Business Overview
11.1.3 Airdoc Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.1.4 Airdoc Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.1.5 Airdoc Technology Recent Development
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Details
11.2.2 Digital Diagnostics Business Overview
11.2.3 Digital Diagnostics Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.2.4 Digital Diagnostics Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.2.5 Digital Diagnostics Recent Development
11.3 Eyenuk
11.3.1 Eyenuk Company Details
11.3.2 Eyenuk Business Overview
11.3.3 Eyenuk Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.3.4 Eyenuk Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.3.5 Eyenuk Recent Development
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Details
11.4.2 RetinaLyze System Business Overview
11.4.3 RetinaLyze System Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.4.4 RetinaLyze System Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.4.5 RetinaLyze System Recent Development
11.5 Optomed
11.5.1 Optomed Company Details
11.5.2 Optomed Business Overview
11.5.3 Optomed Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.5.4 Optomed Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.5.5 Optomed Recent Development
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Details
11.6.2 Sibionics Technology Business Overview
11.6.3 Sibionics Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.6.4 Sibionics Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.6.5 Sibionics Technology Recent Development
11.7 Aeye Health
11.7.1 Aeye Health Company Details
11.7.2 Aeye Health Business Overview
11.7.3 Aeye Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.7.4 Aeye Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.7.5 Aeye Health Recent Development
11.8 VUNO
11.8.1 VUNO Company Details
11.8.2 VUNO Business Overview
11.8.3 VUNO Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.8.4 VUNO Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.8.5 VUNO Recent Development
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Details
11.9.2 Medimaging Integrated Solution Business Overview
11.9.3 Medimaging Integrated Solution Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.9.4 Medimaging Integrated Solution Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.9.5 Medimaging Integrated Solution Recent Development
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Details
11.10.2 EyRIS (SELENA+) Business Overview
11.10.3 EyRIS (SELENA+) Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.10.4 EyRIS (SELENA+) Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.10.5 EyRIS (SELENA+) Recent Development
11.11 Vistel
11.11.1 Vistel Company Details
11.11.2 Vistel Business Overview
11.11.3 Vistel Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.11.4 Vistel Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.11.5 Vistel Recent Development
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Details
11.12.2 RETINA-AI Health Business Overview
11.12.3 RETINA-AI Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.12.4 RETINA-AI Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.12.5 RETINA-AI Health Recent Development
11.13 Acer Medical
11.13.1 Acer Medical Company Details
11.13.2 Acer Medical Business Overview
11.13.3 Acer Medical Diabetic Retinopathy (DR) Artificial Intelligence Screening System Introduction
11.13.4 Acer Medical Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
11.13.5 Acer Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hardware
Table 3. Key Players of Software
Table 4. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region (2019-2024)
Table 8. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region (2025-2030)
Table 10. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Trends
Table 11. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Drivers
Table 12. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Challenges
Table 13. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Restraints
Table 14. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Players (2019-2024)
Table 16. Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System as of 2023)
Table 17. Ranking of Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Headquarters and Area Served
Table 20. Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Product and Application
Table 21. Global Key Players of Diabetic Retinopathy (DR) Artificial Intelligence Screening System, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Type (2019-2024)
Table 25. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Type (2025-2030)
Table 27. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Application (2019-2024)
Table 29. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue Market Share by Application (2025-2030)
Table 31. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Country (2025-2030) & (US$ Million)
Table 46. Airdoc Technology Company Details
Table 47. Airdoc Technology Business Overview
Table 48. Airdoc Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 49. Airdoc Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 50. Airdoc Technology Recent Development
Table 51. Digital Diagnostics Company Details
Table 52. Digital Diagnostics Business Overview
Table 53. Digital Diagnostics Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 54. Digital Diagnostics Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 55. Digital Diagnostics Recent Development
Table 56. Eyenuk Company Details
Table 57. Eyenuk Business Overview
Table 58. Eyenuk Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 59. Eyenuk Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 60. Eyenuk Recent Development
Table 61. RetinaLyze System Company Details
Table 62. RetinaLyze System Business Overview
Table 63. RetinaLyze System Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 64. RetinaLyze System Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 65. RetinaLyze System Recent Development
Table 66. Optomed Company Details
Table 67. Optomed Business Overview
Table 68. Optomed Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 69. Optomed Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 70. Optomed Recent Development
Table 71. Sibionics Technology Company Details
Table 72. Sibionics Technology Business Overview
Table 73. Sibionics Technology Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 74. Sibionics Technology Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 75. Sibionics Technology Recent Development
Table 76. Aeye Health Company Details
Table 77. Aeye Health Business Overview
Table 78. Aeye Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 79. Aeye Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 80. Aeye Health Recent Development
Table 81. VUNO Company Details
Table 82. VUNO Business Overview
Table 83. VUNO Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 84. VUNO Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 85. VUNO Recent Development
Table 86. Medimaging Integrated Solution Company Details
Table 87. Medimaging Integrated Solution Business Overview
Table 88. Medimaging Integrated Solution Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 89. Medimaging Integrated Solution Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 90. Medimaging Integrated Solution Recent Development
Table 91. EyRIS (SELENA+) Company Details
Table 92. EyRIS (SELENA+) Business Overview
Table 93. EyRIS (SELENA+) Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 94. EyRIS (SELENA+) Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 95. EyRIS (SELENA+) Recent Development
Table 96. Vistel Company Details
Table 97. Vistel Business Overview
Table 98. Vistel Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 99. Vistel Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 100. Vistel Recent Development
Table 101. RETINA-AI Health Company Details
Table 102. RETINA-AI Health Business Overview
Table 103. RETINA-AI Health Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 104. RETINA-AI Health Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 105. RETINA-AI Health Recent Development
Table 106. Acer Medical Company Details
Table 107. Acer Medical Business Overview
Table 108. Acer Medical Diabetic Retinopathy (DR) Artificial Intelligence Screening System Product
Table 109. Acer Medical Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024) & (US$ Million)
Table 110. Acer Medical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Picture
Figure 2. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Type: 2023 VS 2030
Figure 4. Hardware Features
Figure 5. Software Features
Figure 6. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Application: 2023 VS 2030
Figure 8. Medical Institutions Case Studies
Figure 9. Great Health Scene Case Studies
Figure 10. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Report Years Considered
Figure 11. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region: 2023 VS 2030
Figure 14. Global Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Players in 2023
Figure 15. Global Top Diabetic Retinopathy (DR) Artificial Intelligence Screening System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy (DR) Artificial Intelligence Screening System as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Diabetic Retinopathy (DR) Artificial Intelligence Screening System Revenue in 2023
Figure 17. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)
Figure 19. United States Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)
Figure 23. Germany Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Region (2019-2030)
Figure 31. China Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)
Figure 39. Mexico Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Share by Country (2019-2030)
Figure 43. Turkey Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. UAE Diabetic Retinopathy (DR) Artificial Intelligence Screening System Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Airdoc Technology Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 47. Digital Diagnostics Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 48. Eyenuk Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 49. RetinaLyze System Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 50. Optomed Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 51. Sibionics Technology Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 52. Aeye Health Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 53. VUNO Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 54. Medimaging Integrated Solution Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 55. EyRIS (SELENA+) Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 56. Vistel Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 57. RETINA-AI Health Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 58. Acer Medical Revenue Growth Rate in Diabetic Retinopathy (DR) Artificial Intelligence Screening System Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
